Teva’s Challenges Spur CEO Change
With the announcement that Erez Vigodman will resign as CEO, Teva continues to see leadership changes as the firm struggles to adapt to competitive pressure in its generics segment and potential imminent generic competition on Copaxone. Vigodman’s exit follows the abrupt departure of the CEO of its generics segment, Siggi Olafsson, in December. We’re not particularly surprised to see the announcement, given the recent shortfall in generics segment performance and lowered outlook for 2017. While ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.